NovaBay Pharma's total assets for Q3 2025 were $3.49M, a decrease of -49.54% from the previous quarter. NBY total liabilities were $1.85M for the fiscal quarter, a -30.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.